Who are in the management team of Corcept Therapeutics, Inc.?

Jun 22 2025 10:20 PM IST
share
Share Via
As of March 2022, the management team of Corcept Therapeutics, Inc. includes Mr. James Wilson (Independent Chairman), Dr. Joseph Belanoff (CEO), Dr. Gillian Cannon, and several independent directors: Mr. Gregg Alton, Mr. George Baker, Mr. David Mahoney, and Ms. Kimberly Park. They oversee the company's strategic direction and operations.
As of March 2022, the management team of Corcept Therapeutics, Inc. includes the following individuals:

- Mr. James Wilson, Independent Chairman of the Board
- Dr. Joseph Belanoff, President, Chief Executive Officer, and Director
- Dr. Gillian Cannon, Director
- Mr. Gregg Alton, Independent Director
- Mr. George Baker, Independent Director
- Mr. David Mahoney, Independent Director
- Ms. Kimberly Park, Independent Director

This team is responsible for guiding the company's strategic direction and operations.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News